231: BU's Covid tinkering, FDA on trial, & why it's hard to take drugs off the market episode artwork

EPISODE · Oct 20, 2022 · 34 MIN

231: BU's Covid tinkering, FDA on trial, & why it's hard to take drugs off the market

from The Readout Loud · host STAT

Lawyer and bioethicist ​​Holly Fernandez Lynch joins us to explain a watershed test of the FDA's authority to revoke drug approvals. And STAT's Helen Branswell calls in to discuss the headline-grabbing research at Boston University involving a lab-developed version of the virus that causes Covid-19.

Episode metadata supplied by the publisher feed · Published Oct 20, 2022

Embed this episode

NOW PLAYING

231: BU's Covid tinkering, FDA on trial, & why it's hard to take drugs off the market

0:00 34:32

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 34 minutes long.

When was this The Readout Loud episode published?

This episode was published on October 20, 2022.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!